Tania Small, SVP, Head of Medical Affairs at Bristol Myers Squibb, shared a post on LinkedIn:
“Let’s talk about lung Cancer Differently.
Anyone with lungs can be at risk- and that’s exactly why early detection matters.
In this video Dr. Nathan Pennell and I share why early detection and molecular testing are so critical- and why lung cancer needs a different kind of urgency.
Here are actions that make a real difference:
- Low-dose CT screening for those at risk
- Comprehensive molecular testing
- Clinical trials and equitable access
Awareness is the starting point-action changes outcomes!”
Proceed to the video attached to the post.
Nathan Pennell, SVP, Head of Global Medical Oncology at Bristol Myers Squibb, shared Tania Small’s post on LinkedIn, adding:
“For Lung Cancer Awareness Month, don’t just focus on awareness but take action to change things!”
More posts featuring Nathan Pennell.